$ONVO
ORGANOVO HOLDINGS, INC.

2013 Q4 Form 10-Q Financial Statement

#000119312513435186 Filed on November 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $135.0K $23.00K $469.0K
YoY Change -61.32% -95.1%
Cost Of Revenue $0.00
YoY Change
Gross Profit $470.0K
YoY Change
Gross Profit Margin 100.21%
Selling, General & Admin $2.379M $4.003M $2.981M
YoY Change 11.12% 34.28% 9836.67%
% of Gross Profit 634.26%
Research & Development $2.359M $1.622M $1.106M
YoY Change 108.76% 46.65%
% of Gross Profit 235.32%
Depreciation & Amortization $100.0K $100.0K $80.00K
YoY Change 25.0% 25.0%
% of Gross Profit 17.02%
Operating Expenses $4.738M $5.625M $4.087M
YoY Change 44.85% 37.63% 13523.33%
Operating Profit -$4.626M -$5.602M -$3.618M
YoY Change 58.32% 54.84%
Interest Expense -$580.0K -$4.780M $42.25M
YoY Change -91.27% -111.31%
% of Operating Profit
Other Income/Expense, Net -$582.0K -$4.784M $42.10M
YoY Change -91.24% -111.36%
Pretax Income -$5.210M -$10.39M $38.48M
YoY Change -45.56% -127.0% -192500.0%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$5.208M -$10.39M $38.48M
YoY Change -45.55% -126.99% -192490.0%
Net Earnings / Revenue -3857.78% -45156.52% 8204.26%
Basic Earnings Per Share -$0.14 $0.87
Diluted Earnings Per Share -$1.350M -$0.14 $0.69
COMMON SHARES
Basic Shares Outstanding 77.28M shares 72.72M shares 44.10M shares
Diluted Shares Outstanding 72.72M shares 55.85M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.82M $53.36M $7.680M
YoY Change 236.17% 594.79%
Cash & Equivalents $49.82M $53.36M $7.676M
Short-Term Investments
Other Short-Term Assets $620.0K $300.0K $140.0K
YoY Change 16.98% 114.29%
Inventory $82.00K $74.00K $310.0K
Prepaid Expenses
Receivables $100.0K
Other Receivables $0.00
Total Short-Term Assets $50.53M $53.74M $8.230M
YoY Change 218.47% 552.92%
LONG-TERM ASSETS
Property, Plant & Equipment $915.0K $1.031M $610.0K
YoY Change 28.15% 69.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $92.00K $94.00K $210.0K
YoY Change 13.58% -55.24%
Total Long-Term Assets $1.086M $1.163M $810.0K
YoY Change 22.99% 43.58%
TOTAL ASSETS
Total Short-Term Assets $50.53M $53.74M $8.230M
Total Long-Term Assets $1.086M $1.163M $810.0K
Total Assets $51.62M $54.90M $9.040M
YoY Change 208.17% 507.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $311.0K $477.0K $60.00K
YoY Change -26.82% 695.0% 100.0%
Accrued Expenses $1.559M $1.583M $830.0K
YoY Change 58.92% 90.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $2.901M $2.940M $980.0K
YoY Change -86.83% 200.0% 3166.67%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $20.00K
YoY Change -50.0% -50.0%
Other Long-Term Liabilities $10.00K $10.00K $35.47M
YoY Change -99.97%
Total Long-Term Liabilities $20.00K $20.00K $35.49M
YoY Change 0.0% -99.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.901M $2.940M $980.0K
Total Long-Term Liabilities $20.00K $20.00K $35.49M
Total Liabilities $2.914M $2.956M $36.47M
YoY Change -86.79% -91.89% 121466.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $77.00K $77.00K
YoY Change 30.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.70M $51.94M -$27.42M
YoY Change
Total Liabilities & Shareholders Equity $51.62M $54.90M $9.040M
YoY Change 208.17% 507.28%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$5.208M -$10.39M $38.48M
YoY Change -45.55% -126.99% -192490.0%
Depreciation, Depletion And Amortization $100.0K $100.0K $80.00K
YoY Change 25.0% 25.0%
Cash From Operating Activities -$3.900M -$3.600M -$2.300M
YoY Change 96.97% 56.52%
INVESTING ACTIVITIES
Capital Expenditures $20.00K -$20.00K -$180.0K
YoY Change -120.0% -88.89%
Acquisitions
YoY Change
Other Investing Activities -$40.00K $0.00 $0.00
YoY Change
Cash From Investing Activities -$20.00K -$20.00K -$170.0K
YoY Change -81.82% -88.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $43.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 390.0K 44.11M 1.680M
YoY Change -95.77% 2525.6%
NET CHANGE
Cash From Operating Activities -3.900M -3.600M -2.300M
Cash From Investing Activities -20.00K -20.00K -170.0K
Cash From Financing Activities 390.0K 44.11M 1.680M
Net Change In Cash -3.530M 40.49M -790.0K
YoY Change -149.44% -5225.32%
FREE CASH FLOW
Cash From Operating Activities -$3.900M -$3.600M -$2.300M
Capital Expenditures $20.00K -$20.00K -$180.0K
Free Cash Flow -$3.920M -$3.580M -$2.120M
YoY Change 108.51% 68.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 onvo Business Acquisition Conversion Ratio
BusinessAcquisitionConversionRatio
0.0001 pure
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10353000
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.5
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77278303 shares
CY2007Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2008Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-96000
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-966000
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2301000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1111295 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
896256 shares
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1835000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7676000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1162044 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.48
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2690586 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
650000 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5303000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
38300
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3041476
CY2012Q4 onvo Class Of Warrant Or Right Amended Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightAmendedExercisePriceOfWarrantsOrRights
0.80
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76818625 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1395841 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76818625 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
689492 shares
CY2013Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12443394 shares
CY2013Q3 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4174952 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.85
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1583000
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
242000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132387000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1411000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
477000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2940000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
506000
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
795000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3618567 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
600065 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000
CY2013Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75269000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
641000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8969000
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51942000
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
10000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
CY2013Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
800000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
170000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
493000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
75000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
77000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54898000
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2013Q3 us-gaap Liabilities
Liabilities
2956000
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
6000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
38800
CY2013Q3 us-gaap Assets Current
AssetsCurrent
53735000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
94000
CY2013Q3 us-gaap Assets
Assets
54898000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53357000
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
74000
CY2013Q3 us-gaap Inventory Net
InventoryNet
74000
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5477584
CY2013Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
80522000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
304000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13631682
CY2013Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
38000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5406000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1031000
CY2007Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64686919 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64686919 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
985742 shares
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8382000
CY2013Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6898000
CY2013Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15000
CY2013Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6900000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
65000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17375000
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2013Q1 us-gaap Liabilities
Liabilities
8406000
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Assets Current
AssetsCurrent
16144000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2013Q1 us-gaap Assets
Assets
17375000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15628000
CY2013Q1 us-gaap Grants Receivable
GrantsReceivable
101000
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
88000
CY2013Q1 us-gaap Inventory Net
InventoryNet
88000
CY2013Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
66365000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5909154
CY2013Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
88000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1045000
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
269657 shares
CY2013Q2 onvo Class Of Warrant Or Right Exercise Price Of Warrants After Amendment
ClassOfWarrantOrRightExercisePriceOfWarrantsAfterAmendment
0.85
CY2013Q2 onvo Class Of Warrant Or Right Exercise Price Of Warrants Before Amendment
ClassOfWarrantOrRightExercisePriceOfWarrantsBeforeAmendment
1.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.01012 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59359415 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8049 pure
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1810831 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4159000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43614514 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15700000 shares
us-gaap Revenues
Revenues
728000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
us-gaap Profit Loss
ProfitLoss
3093000
us-gaap Revenue From Grants
RevenueFromGrants
95000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5068000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
4000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8161000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
283000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
250000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8315000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1782000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-194000
us-gaap Share Based Compensation
ShareBasedCompensation
1281000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2677000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
429000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-300000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
36000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1759000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
157000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4037000
onvo Number Of Warrants Exercised
NumberOfWarrantsExercised
1820975 shares
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
1768000
onvo Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-8315000
onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
3728000
onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
8300000
onvo Cashless Exercise For Issuance Of Common Stock
CashlessExerciseForIssuanceOfCommonStock
42356 shares
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
96000
onvo Revenue From Collaborations
RevenueFromCollaborations
633000
onvo Warrants Cashless Exercise Number
WarrantsCashlessExerciseNumber
52500 shares
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-50000
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1768475 shares
dei Trading Symbol
TradingSymbol
ONVO
dei Entity Registrant Name
EntityRegistrantName
ORGANOVO HOLDINGS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001497253
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
60000 shares
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Revenue Arrangements with Multiple Deliverables</p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company occasionally enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#x201C;VSOE&#x201D;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable.</p> <p style="MARGIN-TOP: 12pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes revenue for delivered elements only when it determines there are no uncertainties regarding customer acceptance. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#x2019;s results of operations.</p> <p style="MARGIN-TOP: 12pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value.</p> </div>
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Product Revenue</p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. The Company recognizes product revenues upon shipment to distributors, provided that (i)&#xA0;the price is substantially fixed or determinable at the time of sale; (ii)&#xA0;the distributor&#x2019;s obligation to pay the Company is not contingent upon resale of the products; (iii)&#xA0;title and risk of loss passes to the distributor at the time of shipment; (iv)&#xA0;the distributor has economic substance apart from that provided by the Company; (v)&#xA0;the Company has no significant obligation to the distributor to bring about the resale of the products; and (vi)&#xA0;future returns can be reasonably estimated. For any sales that do not meet all of the above criteria, revenue is deferred until all such criteria have been met.</p> <p>&#xA0;</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00842 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68776718 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8482 pure
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1870986 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.09
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between two and five years.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6256000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
574540 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68776718 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10855 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y8M12D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7300 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.85
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <i>Use of estimates</i></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
356250 shares
us-gaap Revenues
Revenues
129000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
767000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
us-gaap Profit Loss
ProfitLoss
-14157000
us-gaap Revenue From Grants
RevenueFromGrants
12000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9336000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
5000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4821000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2088000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-4811000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44111000
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
19000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22192
us-gaap Share Based Compensation
ShareBasedCompensation
2088000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
37729000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
803000
us-gaap Interest Expense
InterestExpense
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-164000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
72000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3061000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
190000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
210000
us-gaap Restructuring Costs
RestructuringCosts
2100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6404000
onvo Number Of Warrants Exercised
NumberOfWarrantsExercised
2278557 shares
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
44096000
onvo Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
43445000
onvo Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
4811000
onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
10147000
onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
4800000
onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
12000
onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
10147000
onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
767000
onvo Cashless Exercise For Issuance Of Common Stock
CashlessExerciseForIssuanceOfCommonStock
1627486 shares
onvo Companys Stockholders Retained Voting Interest
CompanysStockholdersRetainedVotingInterest
0.25 pure
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
10147000
onvo Fee For Additional Research And Development Services
FeeForAdditionalResearchAndDevelopmentServices
135000
onvo Former Security Holders Common Stock Voting Interest
FormerSecurityHoldersCommonStockVotingInterest
0.75 pure
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-101000
onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
12000
onvo Research And Development Services Contract Value
ResearchAndDevelopmentServicesContractValue
1500000
onvo Revenue From Collaborations
RevenueFromCollaborations
117000
onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
651000
onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
72000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
767000
onvo Warrants Cashless Exercise Number
WarrantsCashlessExerciseNumber
2035057 shares
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
50000
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1817928 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22034000
us-gaap Revenues
Revenues
3192000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
304000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
438000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
224000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
us-gaap Profit Loss
ProfitLoss
-80522000
us-gaap Revenue From Grants
RevenueFromGrants
955000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27028000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
114000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-162000
us-gaap Interest Paid
InterestPaid
10000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
14000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53494000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
737000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1097000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-26782000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
528000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76640000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
134000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4630000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
81000
us-gaap Share Based Compensation
ShareBasedCompensation
4388000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
53357000
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2010 us-gaap Profit Loss
ProfitLoss
-1339000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1583000
us-gaap Interest Expense
InterestExpense
3484000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
477000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1249000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
32743000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
890000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11143000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
38000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
621000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
250000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
438000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
966000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2084000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18943000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
72534000
onvo Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
26782000
onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
485000
onvo Convertible Notes Principal Amount
ConvertibleNotesPrincipalAmount
4530000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
57337000
onvo Fair Value Of Warrant Liabilities In Excess Of Proceeds Received
FairValueOfWarrantLiabilitiesInExcessOfProceedsReceived
19019000
onvo Financing Transaction Costs In Excess Of Proceeds Received
FinancingTransactionCostsInExcessOfProceedsReceived
2130000
onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
495000
onvo Issuance Of Common Stock To Note Holders Shares
IssuanceOfCommonStockToNoteHoldersShares
9202215 shares
onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
650000 shares
onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
77000
onvo Purchased Equipment Through Capital Lease
PurchasedEquipmentThroughCapitalLease
34000
onvo Repayment Of Convertible Notes And Interest Payable
RepaymentOfConvertibleNotesAndInterestPayable
110000
onvo Revenue From Collaborations
RevenueFromCollaborations
2013000
onvo Warrant Or Right Expense Or Revenue Recognized
WarrantOrRightExpenseOrRevenueRecognized
890000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
2653000
onvo Warrants And Related Beneficial Conversion Feature Value
WarrantsAndRelatedBeneficialConversionFeatureValue
824000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-38000
onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
890000
onvo Warrant Issued In Connection With Convertible Notes Payable
WarrantIssuedInConnectionWithConvertibleNotesPayable
1260000
us-gaap Profit Loss
ProfitLoss
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10350000 shares
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000
CY2012Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
7700000
CY2009 us-gaap Profit Loss
ProfitLoss
-872000
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1111000
CY2011 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
239000
CY2011 us-gaap Profit Loss
ProfitLoss
-4383000
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3490000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9000
CY2008 us-gaap Profit Loss
ProfitLoss
-98000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1380000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.95
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2023394 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
224064 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.25
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1143735 shares
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
890000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2012 us-gaap Profit Loss
ProfitLoss
-43553000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1435000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
564641
CY2012 onvo Adjustments To Additional Paid In Capital Loss On Inducement To Exercise Warrants
AdjustmentsToAdditionalPaidInCapitalLossOnInducementToExerciseWarrants
1904000
CY2012 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23321000
CY2012 onvo Amount Of Warrant Tender Offer
AmountOfWarrantTenderOffer
9600000 shares
CY2012 onvo Class Of Warrant Or Right Induced Exercise Expense
ClassOfWarrantOrRightInducedExerciseExpense
1900000
CY2012 onvo Costs Associated With Merger
CostsAssociatedWithMerger
13723000
CY2012 onvo Duration After Which Warrants Are Exercisable
DurationAfterWhichWarrantsAreExercisable
P5Y
CY2012 onvo Issuance Of Common Stock Through Conversion Of Notes Payable And Accrued Interest In Connection With Merger
IssuanceOfCommonStockThroughConversionOfNotesPayableAndAccruedInterestInConnectionWithMerger
1526000
CY2012 onvo Issuance Of Common Stock Through Private Placements In Connection With Merger
IssuanceOfCommonStockThroughPrivatePlacementsInConnectionWithMerger
13723000
CY2012 onvo Number Of Shares To Be Exchanged For Amended Outstanding Warrants
NumberOfSharesToBeExchangedForAmendedOutstandingWarrants
14500000 shares
CY2012 onvo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndExpirationsInPeriod
185516 shares
CY2012 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
10991000
CY2012 onvo Warrant Induced Exercise Placement Agent Fees Legal Cost And Other Fees Expense
WarrantInducedExercisePlacementAgentFeesLegalCostAndOtherFeesExpense
400000
CY2012 onvo Number Of Offerings Under Private Placement Reverse Merger
NumberOfOfferingsUnderPrivatePlacementReverseMerger
3 Private_placement
CY2012 onvo Number Of Agreement With Consultants For Services
NumberOfAgreementWithConsultantsForServices
4 Agreement
CY2012Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1500000
CY2012Q1 onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
25387
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
55000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.93
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
927981 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
196612 shares
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-16120000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
848000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2013Q1 onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
65000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23869000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
1886000
CY2013Q1 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2013Q1 onvo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndExpirationsInPeriod
34690 shares
CY2013Q1 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
3724000
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00816 pure
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55849360 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9621 pure
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2012Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1673247 shares
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y15D
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.32
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44099554 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11700000 shares
CY2012Q3 us-gaap Revenues
Revenues
469000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2012Q3 us-gaap Profit Loss
ProfitLoss
38478000
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
95000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3618000
CY2012Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42096000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1106000
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
105000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2981000
CY2012Q3 onvo Number Of Warrants Exercised
NumberOfWarrantsExercised
1675975 shares
CY2012Q3 onvo Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-42252000
CY2012Q3 onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
2854000
CY2012Q3 onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
42300000
CY2012Q3 onvo Cashless Exercise For Issuance Of Common Stock
CashlessExerciseForIssuanceOfCommonStock
4772 shares
CY2012Q3 onvo Revenue From Collaborations
RevenueFromCollaborations
374000
CY2012Q3 onvo Warrants Cashless Exercise Number
WarrantsCashlessExerciseNumber
7500 shares
CY2012Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1668475 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00630 pure
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72716031 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8260 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
160540 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2013Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1670851 shares
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.00
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
160540 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72716031 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
296250 shares
CY2013Q3 us-gaap Revenues
Revenues
23000
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-10386000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5602000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4784000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1599000
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
105000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4026000
CY2013Q3 onvo Number Of Warrants Exercised
NumberOfWarrantsExercised
2026428 shares
CY2013Q3 onvo Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
4787000
CY2013Q3 onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
10018000
CY2013Q3 onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
4800000
CY2013Q3 onvo Cashless Exercise For Issuance Of Common Stock
CashlessExerciseForIssuanceOfCommonStock
1427351 shares
CY2013Q3 onvo Fee For Additional Research And Development Services
FeeForAdditionalResearchAndDevelopmentServices
135000
CY2013Q3 onvo Research And Development Services Contract Value
ResearchAndDevelopmentServicesContractValue
1500000
CY2013Q3 onvo Revenue From Collaborations
RevenueFromCollaborations
23000
CY2013Q3 onvo Warrants Cashless Exercise Number
WarrantsCashlessExerciseNumber
1782928 shares
CY2013Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1782928 shares

Files In Submission

Name View Source Status
0001193125-13-435186-index-headers.html Edgar Link pending
0001193125-13-435186-index.html Edgar Link pending
0001193125-13-435186.txt Edgar Link pending
0001193125-13-435186-xbrl.zip Edgar Link pending
d604155d10q.htm Edgar Link pending
d604155dex311.htm Edgar Link pending
d604155dex312.htm Edgar Link pending
d604155dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
onvo-20130930.xml Edgar Link completed
onvo-20130930.xsd Edgar Link pending
onvo-20130930_cal.xml Edgar Link unprocessable
onvo-20130930_def.xml Edgar Link unprocessable
onvo-20130930_lab.xml Edgar Link unprocessable
onvo-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending